Severe intestinal perforation due to bevacizumab

Jingpu Xu,Wei Kong,Wenting Dai,Liya Zheng,Changfang Fu

DOI: https://doi.org/10.3760/cma.j.issn.1008-5734.2015.04.020

2015-01-01

Abstract:A 65-year-old female patient was given treatment scheme of bevacizumab(0. 386 g,the first day),oxaliplatin(150 mg,the first day)and capecitabine(1 g,twice daily,the first day to the 14th day)for colon cancer with liver metastasis. Twenty-three days after administration,the patient developed upper abdominal pain. She was diagnosed of gastrointestinal perforation and diffuse peritonitis by abdominal X-ray and CT scan. Emergency exploratory laparotomy was performed and a perforation with a size about 5 cm × 2 cm was found at the location of ascending colon 5 cm away from ileocecus. Then an ascending colon and terminal ileum fistula operation was performed. After the patientˊs condition was stable,she was given oxaliplatin and capecitabine to continue treatment.